Chemical Structure (Lantus 01)
Lantus Injection, Solution
Product Images NDC 0088-2220
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 36 technical images submitted to the FDA as part of the official labeling for Lantus (NDC 0088-2220). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Lantus 02)
Figure (Lantus 03)
Figure (Lantus 04)
Figure (Lantus 05)
Figure (Lantus 06)
Figure (Lantus 07)
Figure (Lantus 08)
This appears to be a list of body parts: Upper arms, Stomach, and Thighs. It is possible that this text is a reference to areas of the body that may be targeted for fitness or health-related purposes.*
Figure (Lantus 09)
Figure (Lantus 10)
Figure (Lantus 11)
This is a list of body parts including upper arms, stomach, and thighs.*
Figure (Lantus 12)
The text seems to be a description of a diabetes pen. It refers to the different parts of the pen: the pen cap, the pen needle (not included), the pen body, the dose, the protective seal, the insulin reservoir window, the needle, the rubber seal, and the button. There is also an illustration that shows the different parts. This text might be useful for someone who needs to buy or use a diabetes pen, but it lacks more detailed information, such as the brand, model or instructions for use.*
Figure (Lantus 13)
Figure (Lantus 14)
Figure (Lantus 15)
Figure (Lantus 16)
Figure (Lantus 17)
Figure (Lantus 18)
Figure (Lantus 19)
Principal Display Panel (10 mL Vial Carton)
Principal Display Panel (3 mL Pen Carton)
Lantus 22
Lantus 23
Lantus 24
Lantus 25
Lantus 26
Lantus 27
Lantus 28
Lantus 29
Lantus 30
Lantus 31
Lantus 32
Lantus 33
Lantus 34
Lantus 35
This is a description of Lantus insulin glargine injection, a medicine used for subcutaneous injection only. The medicine comes in 100 units/mi. (U-100) and is available in a 10mL multi-dose vial. It is important not to mix it with other insulins and use only a clear and colorless solution with no visible particles. Dosage and administration instructions are provided in the package insert. Unopened vials must be stored in a refrigerator and discarded after the expiration date. Opened vials must be discarded after 28 days if not refrigerated. This product must be used cautiously if pregnant or nursing and under medical supervision. A warning is given to keep it out of reach of children.*
Lantus 36
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
